{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:01:49Z","timestamp":1793887309168,"version":"4.8.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Despite being rare, the Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a serious, possibly fatal condition that may affect both adults and children who may be also burdened by delayed sequelae. It is an adverse drug reaction characterized by widespread skin involvement, fever, lymphadenopathy, visceral involvement, and laboratory abnormalities (eosinophilia, mononucleosis-like atypical lymphocytes). It is more frequently triggered by anticonvulsants, sulphonamides, or antibiotics, the latter being responsible for up to 30% of pediatric cases. The disease typically develops 2\u20138\u2009weeks after exposure to the culprit medication, with fever and widespread skin eruption; mild viral prodromes are possible. Unfortunately, diagnosis is challenging due to the absence of a reliable test; however, a score by the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) allows to classify suspect patients into no, possible, probable, or definite DRESS cases. Moreover, rapid-onset DRESS syndrome has been described in recent years. It affects children more often than adults and differs from the most common form because it appears \u226415\u2009days vs. &amp;gt;15\u2009days after starting the drug, it is usually triggered by antibiotics or iodinated contrast media rather than by anticonvulsants and has a higher presence of lymphadenopathy. Differential diagnosis between rapid-onset antibiotic-driven DRESS syndrome, viral exanthems, or other drug eruptions may be challenging, but it is mandatory to define it as early as possible to start adequate treatment and monitor possible complications. The present review reports the latest evidence about the diagnosis and treatment of pediatric DRESS syndrome.<\/jats:p>","DOI":"10.3389\/fmed.2023.1108345","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T19:17:39Z","timestamp":1690571859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review"],"prefix":"10.3389","volume":"10","author":[{"given":"Elisa","family":"Manieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Lanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/pde.14044","article-title":"Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature","volume":"37","author":"Metterle","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"38","author":"Cardones","year":"2020","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) \/ drug-induced hypersensitivity syndrome (DIHS): a review of current concepts","volume":"87","author":"Criado","year":"2012","journal-title":"An Bras Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00431-021-04010-5","article-title":"Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after \u03b2-lactams intake: a diagnostic challenge","volume":"180","author":"Dondi","year":"2021","journal-title":"Eur J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaip.2021.07.025","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): series of 49 French pediatric cases","volume":"10","author":"Bedouelle","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/pde.13949","article-title":"Drug reaction with eosinophilia and systemic symptoms: pediatric case series and literature review","volume":"36","author":"Oberlin","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/pde.14446","article-title":"Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature, with a focus on relapsing cases","volume":"38","author":"Afiouni","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.23750\/abm.v90i3-S.8167","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in children","volume":"90","author":"Mori","year":"2019","journal-title":"Acta Bio-Med Atenei Parm"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1525-1470.2009.00870.x","article-title":"Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS)","volume":"26","author":"Newell","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bjd.13512","article-title":"Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome","volume":"172","author":"Ahluwalia","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13052-018-0535-4","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis","volume":"44","author":"Castellazzi","year":"2018","journal-title":"Ital J Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000509712","article-title":"Drug reaction with eosinophilia and systemic symptoms secondary to naproxen: a case report and literature review","volume":"3","author":"Sasi","year":"2020","journal-title":"Case Rep Acute Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1939-4551-6-18","article-title":"Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy","volume":"6","author":"S\u00e1nchez-Borges","year":"2013","journal-title":"World Allergy Organ J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2500\/aap.2012.33.3498","article-title":"The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"33","author":"Blumenthal","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref20","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthetic Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/biomedicines10050999","article-title":"Drug reaction with eosinophilia and systemic symptoms (DReSS)\/drug-induced hypersensitivity syndrome (DiHS)\u2014readdressing the DReSS","volume":"10","author":"Stirton","year":"2022","journal-title":"Biomedicine"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000458725","article-title":"Multiple drug hypersensitivity","volume":"172","author":"Pichler","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/a-1857-5062","article-title":"Multiple drug hypersensitivity in a small child with DRESS syndrome - a case report","volume":"235","author":"Gruber","year":"2023","journal-title":"Klin Padiatr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the Immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"E1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/ajd.12085","article-title":"Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome","volume":"55","author":"Fernando","year":"2014","journal-title":"Australas J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1684\/ejd.2010.0821","article-title":"Amoxicillin-induced flare in patients with DRESS (drug reaction with eosinophilia and systemic symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on human herpesvirus 6 replication in vitro","volume":"20","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatol EJD"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","volume":"10","author":"Schunkert","year":"2021","journal-title":"Curr Dermatol Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.29784\/DS.200912.0001","article-title":"Severe cutaneous adverse reactions to drugs (SCAR): definitions, diagnostic criteria, genetic predisposition","volume":"27","author":"Roujeau","year":"2009","journal-title":"Dermatol Sin."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fphar.2020.00969","article-title":"Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions","volume":"11","author":"Chang","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jaad.2020.03.081","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature","volume":"83","author":"Kim","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaip.2016.03.020","article-title":"Hypereosinophilia in children and adults: a retrospective comparison","volume":"4","author":"Williams","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Caba\u00f1as","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"Biomed Res Int"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1097\/INF.0b013e3182a09f20","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications","volume":"32","author":"Cheng","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1111\/pde.12803","article-title":"Drug reaction with eosinophilia and systemic symptoms in children: a prospective study","volume":"33","author":"Sasidharanpillai","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/microorganisms11020346","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses","volume":"11","author":"Ramirez","year":"2023","journal-title":"Microorganisms"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1592\/phco.31.3.332","article-title":"The DRESS syndrome: the great clinical mimicker","volume":"31","author":"Fleming","year":"2011","journal-title":"Pharmacotherapy"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4168\/aair.2014.6.3.216","article-title":"Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/ijd.IJD_582_17","article-title":"Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature","volume":"63","author":"De","year":"2018","journal-title":"Indian J Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian research committee on severe cutaneous adverse reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Joint Bone Spine"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cea.13513","article-title":"Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: a 9-year experience in a tertiary care paediatric hospital setting","volume":"50","author":"Liccioli","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaip.2017.02.013","article-title":"Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study","volume":"5","author":"Dibek Misirlioglu","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2500\/aap.2021.42.200110","article-title":"Evaluation of drug patch tests in children","volume":"42","author":"Yaytokgil","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.aller.2015.02.004","article-title":"Severe delayed skin reactions related to drugs in the paediatric age group: a review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS)","volume":"44","author":"Belver","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/0009922808320703","article-title":"DRESS syndrome: a practical approach for primary care practitioners","volume":"47","author":"Seth","year":"2008","journal-title":"Clin Pediatr (Phila)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mcna.2021.04.001","article-title":"Recognition and Management of Severe Cutaneous Adverse Drug Reactions (including drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis)","volume":"105","author":"Owen","year":"2021","journal-title":"Med Clin North Am"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","article-title":"Management of drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"137","author":"Descamps","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1542\/peds.107.1.e14","article-title":"Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin","volume":"107","author":"Scheuerman","year":"2001","journal-title":"Pediatrics"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2340\/00015555-1168","article-title":"High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome","volume":"92","author":"Kito","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","article-title":"Poor benefit\/risk balance of intravenous immunoglobulins in DRESS","volume":"148","author":"Joly","year":"2012","journal-title":"Arch Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jaip.2017.10.016","article-title":"Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome","volume":"6","author":"Marcus","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaip.2021.10.045","article-title":"New clinical insights into pediatric DRESS to tailor future care?","volume":"10","author":"Awad","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","article-title":"Cyclosporine treatment of drug-induced hypersensitivity syndrome","volume":"152","author":"Kirchhof","year":"2016","journal-title":"JAMA Dermatol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4103\/ijdvl.IJDVL_1084_16","article-title":"Treatment of drug-induced hypersensitivity syndrome with cyclosporine","volume":"83","author":"Zhang","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.anai.2021.08.012","article-title":"Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine","volume":"127","author":"Su","year":"2021","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/jca.21999","article-title":"A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy","volume":"37","author":"Durak","year":"2022","journal-title":"J Clin Apheresis"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1542\/peds.2012-2117","article-title":"Severe DRESS syndrome managed with therapeutic plasma exchange","volume":"131","author":"Alexander","year":"2013","journal-title":"Pediatrics"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s40629-022-00224-7","article-title":"Treatment with IL5-\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"32","author":"Gschwend","year":"2022","journal-title":"Allergo J Int"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1542\/peds.142.1MA5.470","article-title":"DRESS distress: auto-immune complications of DRESS syndrome","volume":"142","author":"Singer","year":"2018","journal-title":"Pediatrics"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1515\/jpem-2021-0685","article-title":"Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature","volume":"35","author":"Tempark","year":"2022","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/bjd.18942","article-title":"The interferon-\u03b3-induced protein 10\/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms*","volume":"183","author":"Yang","year":"2020","journal-title":"Br J Dermatol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"bcr2018225528","DOI":"10.1136\/bcr-2018-225528","article-title":"Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome","volume":"2018","author":"Morita","year":"2018","journal-title":"BMJ Case Rep"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1108345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T19:17:46Z","timestamp":1690571866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1108345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":77,"alternative-id":["10.3389\/fmed.2023.1108345"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1108345","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"article-number":"1108345"}}